A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis
Clinical trial NCT02545868 · COMPLETED
Trial details
- NCT number
- NCT02545868
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-27
- Primary completion
- 2017-02-14
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.